Roth Capital downgraded China Cord Blood (NYSE: CO) from Buy to Neutral with a price target of $6.75 on pending ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE